Investigació Aplicada en Malalties Respiratòries

Research Lines

Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Objectives
  • To characterize infectious exacerbations of chronic obstructive pulmonary disease (COPD)
  • To identify biological markers of infection in COPD
  • To rationalize the use of antibiotics in exacerbations of COPD
Projects in Progress
  • Study of the value of procalcitonin (PCT) in exacerbations of COPD requiring hospitalization
  • Multicenter study of the prevalence of infections due to Aspergillus species in exacerbations of COPD
  • Multicenter study on optimizing the diagnosis of exacerbations in COPD: AUDIEPOC
  • Utility of Antibiotic Treatment in Exacerbations of COPD Without Sputum Purulence: a Randomized, Double-Blind Controlled Clinical Trial on Efficacy and Safety.
Milestones Achieved
  • It has been reported that bacterial infection causes 50% of exacerbations of COPD
  • Bacterial colonization in COPD correlates significantly with the cytokine-associated inflammatory response in bronchoalveolar lavage
  • Sputum purulence as an exacerbation criterion correlates with the existence of bacterial infection in exacerbations of COPD
Future Challenges
  • Identification of biological markers for rapid detection of infectious exacerbations of COPD in severe and outpatient cases
  • Study of the relevance of colonization of the airways by Aspergillus species in patients with severe COPD
  • Search for an effective strategy to rationalize the widespread use of antibiotics in COPD

Publications

  • Geographic differences in clinical characteristics and management of COPD: the EPOCA study

    Marc Miravitlles, Cristina Murio, Gema Tirado-Conde, Gur Levy, Hana Muellerova, Joan B Soriano, Alejandra Ramirez-Venegas, Fanny WS Ko, Byron Canelos-Estrella, Eduardo Giugno, Miguel Bergna, Ivan Chérrez, Antonio Anzueto.

    International Journal of COPD. 2008:3(4) 1–12.

    More information